News & Media / Newsroom
v-WIN Foundation and Alfasigma together to fight one of the leading causes of preventable death: venous thrombosis.
Italy as the hub of an international public awareness project on venous and lymphatic health of the legs to be presented in DUBAI during the EXPO.
An innovative geo-localization software has being launched to increase knowledge & awareness about the disease.
This year, Alfasigma will be Sponsor of the Vein Week, organized by v-WIN Foundation (Scientific Society in Phlebology). The initiative will take place from April, 5th to 11th and on the occasion, a Geomap Calendar software was developed, showing, within an interactive map, vascular events uploaded to the platform by the organizers themselves, upon approval of v-WIN Foundation.
Cosmo Pharmaceuticals will receive a €4m upfront payment Alfasigma plus double digit royalties.
Lumeblue™ was ecently approved by EMA for the detection of lesions during colonoscopy.
Alfasigma will distribute Lumeblue™ in EU, Switzerland, UK, European Economic Area countries, Russia and Mexico.
The new corporate Alfasigma Russia website is online (https://ru.alfasigma.com/). This new website meets most modern technical requirements, has a striking design and a very user friendly interface.
The ideas contest launched by Alfasigma at the beginning of November 2020 concluded the phase relating to the development and delivery of projects by the participants on January 6th. Alfathon collected over 300 entries from both individuals and teams.
3 challenges: from chemistry to software, from technologies to devices to support therapies. The award ceremony scheduled for 2021 at the Alfasigma Pomezia plant.
You’re entering Alfasigma global website
I agree